scPharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
13 Aug 24 | BuyUS$2,000,000 | OrbiMed Advisors LLC | Company | 500,000 | US$4.00 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 43,104 | 0.0861% |
Individual Insiders | 2,095,069 | 4.19% |
Public Companies | 2,167,679 | 4.33% |
Hedge Funds | 4,775,000 | 9.54% |
General Public | 5,239,771 | 10.5% |
VC/PE Firms | 13,367,881 | 26.7% |
Institutions | 22,351,630 | 44.7% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 39.5%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
6,059,528 | US$20.4m | 8.99% | 0.29% | |||
4,775,000 | US$16.0m | 35.5% | 0.26% | |||
4,124,367 | US$13.9m | 17.7% | 7.15% | |||
3,183,986 | US$10.7m | 0% | 0.17% | |||
2,225,790 | US$7.5m | 0.94% | 0.03% | |||
2,167,679 | US$7.3m | 0% | no data | |||
2,049,009 | US$6.9m | 0% | 0.26% | |||
1,825,234 | US$6.1m | 0% | no data | |||
1,768,669 | US$5.9m | 0% | no data | |||
1,708,946 | US$5.7m | 23.3% | no data | |||
1,379,993 | US$4.6m | 58.6% | 0.2% | |||
1,200,647 | US$4.0m | 0% | 0.85% | |||
1,048,938 | US$3.5m | 1.44% | 0.01% | |||
800,000 | US$2.7m | 0% | 0.41% | |||
778,874 | US$2.6m | 84.7% | 0.95% | |||
764,857 | US$2.6m | 0% | 0.3% | |||
750,000 | US$2.5m | 0% | 0.21% | |||
682,135 | US$2.3m | 5.23% | no data | |||
650,265 | US$2.2m | -7.73% | 1.11% | |||
643,342 | US$2.2m | 10.6% | no data | |||
621,665 | US$2.1m | 25% | 0.12% | |||
525,964 | US$1.8m | -28.5% | no data | |||
517,668 | US$1.7m | 0% | 1.91% | |||
501,608 | US$1.7m | 0% | 0.01% | |||
475,555 | US$1.6m | 27% | 0.01% |